Phio Pharmaceuticals Announces American Academy of Dermatology 2026 Presentation Featuring Clinical Study Results from Study of PH-762 for Cutaneous Carcinoma Underscoring Clinical Pipeline Advancemen
Go back to Phio Pharmaceuticals Announces American Academy of Dermatology 2026 Presentation Featuring Clinical Study Results from Study of PH-762 for Cutaneous Carcinoma Underscoring Clinical Pipeline Advancemen| (NASDAQ: PHIO) | Delayed: 1.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.00 | 52 Week High | $ | |||
| Open | $1.00 | 52 Week Low | $ | |||
| Day High | $1.00 | P/E | N/A | |||
| Day Low | $1.00 | EPS | $ | |||
| Volume | 533 | |||||
